January 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreMay 18, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreApril 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreApril 21, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreApril 21, 2026
Multiomics is highly essential in drug discovery because of its advantage in developing precision medicine. North America is dominating the multiomics in drug discovery market because of growing investment in biotechnology industry....
April 21, 2026
Projections indicate that, the global clinical genomics market will increase from USD 1.06 billion in 2024 to USD 5.34 billion by 2034, experiencing a CAGR of 17.54% over the next 10 years. The clinical genomics market is expanding due to growing occurrences of genetic and rare diseases as well as rising advancements in molecular diagnostic testing...
April 21, 2026
The increasing demand for personalized medicine and drug discovery in proteomics is driving the market expansion. Whereas, North America was dominant in the market, due to growing chronic disease incidences and accelerating advancements in healthcare infrastructure, and a strong life sciences industry....
April 21, 2026
Market insights predict the global biological and chemical indicators industry will increase from USD 570.67 million in 2024 to USD 942.03 million by 2034, achieving a CAGR of 5.14%. The growing need for sterilization in the healthcare sector is a crucial factor for market growth. Technological advancements and stringent regulatory policies contrib...
April 21, 2026
Market insights predict, the transcriptomics technologies industry is expected to grow from USD 7.01 billion in 2024 to USD 12.79 billion by 2034, driven by a CAGR of 6.24%. The transcriptomics technologies market is growing rapidly because of the growing focus on the development of omics-based therapeutics. North America is leading the market beca...
April 21, 2026
Market insights predict, the humanized mouse model industry is expected to grow from USD 141.72 million in 2024 to USD 250.94 billion by 2034, driven by a CAGR of 5.84%. The market’s growth is attributed to the rising focus on conducting highly accurate clinical trials for developing therapeutics suitable for human use. North America is...
April 21, 2026
Based on market forecasts, the viral vector development sector will expand from USD 0.89 billion in 2024 to USD 5 billion by 2034, experiencing a CAGR of 18.84%. Globally, different targeted diseases are growing immensely, including genetic disorders like cystic fibrosis and muscular dystrophy, rising cases of cancer, and accelerating technological...
April 21, 2026
According to forecasts, the global 3D bioprinting market will grow from USD 2.58 billion in 2024 to USD 8.42 billion by 2034, with an expected CAGR of 12.54%. The 3D bioprinting market is expanding due to growing demand for organ transplantation as well as rising developments in bioinks. Asia Pacific led the market due to expanding healthcare....
April 21, 2026
According to market projections, the oncology drug discovery sector is growing due to the rising prevalence of cancer and increasing demand for targeted, personalized therapies. Advances in genomics and biotechnology are accelerating the development of innovative cancer treatments....
April 21, 2026
Market insights predict, the fluorescence cell industry is expected to grow from USD 3.17 billion in 2024 to USD 6.37 billion by 2034, driven by a CAGR of 7.29%. The growing research and development activities and technological advancements are the major growth factors of the market. North America led the global market due to the presence of key pl...